Allergen-specific immunotherapy in patients with atopic dermatitis

Min Kyung Lee, Kwang Hoon Lee

Research output: Contribution to journalReview articlepeer-review


Allergy specific immunotherapy (SIT) has been established as an effective treatment in patients with allergic asthma and rhinitis. Although its efficacy has been relatively controversial in patients with atopic dermatitis, recent controlled trials and meta-analyses have reported significant improvement in subjective symptoms in some patients with moderate-to-severe atopic dermatitis. There are a few limitations with SIT safety and patient compliance. Efforts are being made to overcome these limitations, including using recombinant allergens and adjuvants, as well as different routes of administration, such as transdermal delivery. Herein, we review the mechanism of SIT in patients with atopic dermatitis, clinical trial results, its use in clinical practice, limitations, and future direction.

Original languageEnglish
Pages (from-to)91-98
Number of pages8
JournalKorean Journal of Dermatology
Issue number2
Publication statusPublished - 2018 Feb

Bibliographical note

Publisher Copyright:
© 2018 Korean Dermatological Association. All rights reserved.

All Science Journal Classification (ASJC) codes

  • Dermatology


Dive into the research topics of 'Allergen-specific immunotherapy in patients with atopic dermatitis'. Together they form a unique fingerprint.

Cite this